A Feasibility Study for Women Receiving Adjuvant or Neo-adjuvant Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma
The purpose of this project is to assess the feasibility of collecting plasma samples for
cardiac biomarker assessment, and to identify if there is an associations between the
biomarkers, echocardiographic features and the cardiac PET scan results (in patients
receiving radiation therapy). This is the first step in a research program that has an
overall goal of being able to predict early-treatment induced cardiotoxicity in patients
with breast cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society